Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ronald Zolty

Showing results (11-20 of 79) with videos related to

Pageof 8
Sort By:
Expert Review of Cardiovascular Therapy|July 21, 2017
New heart failure pharmacotherapy in clinical trials: a hope in progressAhmed Selim, Ronald Zolty, Yiannis S Chatzizisis
Pharmacology & Therapeutics|March 25, 2017
The evolution of heart failure with reduced ejection fraction pharmacotherapy: What do we have and where are we going?Ahmed Selim, Ronald Zolty, Yiannis S Chatzizisis
The Annals of Pharmacotherapy|December 15, 2005
Probable loop diuretic-induced pancreatitis in a sulfonamide-allergic patientPaul Juang, Robert L Page, Ronald Zolty
The American Journal of Medicine|January 25, 2012
Postmenopausal women with constipation and cardiovascular diseaseJason N Salamon, Jeremy Mazurek, Ronald Zolty
Journal of Cardiac Failure|August 18, 2005
A successful rapid desensitization protocol in a loop diuretic allergic patientPaul Juang, Robert Lee Page, Ronald Zolty
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|August 3, 2020
Reactivation of Cytomegalovirus Following Left Ventricular Assist Device Implantation: A Case-Control StudyScott W Lundgren, Diana F Florescu, Ronald Zolty
Drugs in R&D|August 17, 2013
Effect of race on left ventricular ejection fraction decline after initial improvement with beta blockers in patients with non-ischemic cardiomyopathy: a retrospective analysisIosif Kelesidis, Patrick Hourani, Christopher Varughese, et al.
International Journal of Rheumatic Diseases|March 4, 2014
A novel therapeutic approach in pulmonary arterial hypertension as a complication of adult-onset Still's disease: targeting IL-6Sabeeda Kadavath, Ekaterini Zapantis, Ronald Zolty, et al.
Clinical Cardiology|July 30, 2013
Effects of β-adrenergic blockade on left ventricular remodeling among Hispanics and African Americans with chronic heart failureIosif Kelesidis, Christopher J Varughese, Patrick Hourani, et al.
Cureus|August 25, 2021
Role of Selexipag in Chronic Obstructive Pulmonary Disease (COPD) Patients With Out-of-Proportion Pulmonary HypertensionSherif T Abuserewa, Ahmed Selim, Amr Youssef, et al.
Pageof 8

Showing results (11-20 of 79) with videos related to

Sort By:
Pageof 8
Expert Review of Cardiovascular Therapy|July 21, 2017
New heart failure pharmacotherapy in clinical trials: a hope in progressAhmed Selim, Ronald Zolty, Yiannis S Chatzizisis
Pharmacology & Therapeutics|March 25, 2017
The evolution of heart failure with reduced ejection fraction pharmacotherapy: What do we have and where are we going?Ahmed Selim, Ronald Zolty, Yiannis S Chatzizisis
The Annals of Pharmacotherapy|December 15, 2005
Probable loop diuretic-induced pancreatitis in a sulfonamide-allergic patientPaul Juang, Robert L Page, Ronald Zolty
The American Journal of Medicine|January 25, 2012
Postmenopausal women with constipation and cardiovascular diseaseJason N Salamon, Jeremy Mazurek, Ronald Zolty
Journal of Cardiac Failure|August 18, 2005
A successful rapid desensitization protocol in a loop diuretic allergic patientPaul Juang, Robert Lee Page, Ronald Zolty
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|August 3, 2020
Reactivation of Cytomegalovirus Following Left Ventricular Assist Device Implantation: A Case-Control StudyScott W Lundgren, Diana F Florescu, Ronald Zolty
Drugs in R&D|August 17, 2013
Effect of race on left ventricular ejection fraction decline after initial improvement with beta blockers in patients with non-ischemic cardiomyopathy: a retrospective analysisIosif Kelesidis, Patrick Hourani, Christopher Varughese, et al.
International Journal of Rheumatic Diseases|March 4, 2014
A novel therapeutic approach in pulmonary arterial hypertension as a complication of adult-onset Still's disease: targeting IL-6Sabeeda Kadavath, Ekaterini Zapantis, Ronald Zolty, et al.
Clinical Cardiology|July 30, 2013
Effects of β-adrenergic blockade on left ventricular remodeling among Hispanics and African Americans with chronic heart failureIosif Kelesidis, Christopher J Varughese, Patrick Hourani, et al.
Cureus|August 25, 2021
Role of Selexipag in Chronic Obstructive Pulmonary Disease (COPD) Patients With Out-of-Proportion Pulmonary HypertensionSherif T Abuserewa, Ahmed Selim, Amr Youssef, et al.
Pageof 8